J&J Medical Connect
ERLEADA®

(apalutamide)

This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.

How Should I Take ERLEADA?

Last Updated: 07/15/2024

summary

Here is a passage from the ERLEADA PATIENT INFORMATION which may be helpful to address your question:

What is ERLEADA?

ERLEADA is a prescription medicine used for the treatment of prostate cancer1:

  • that has spread to other parts of the body and still responds to a medical or surgical treatment that lowers testosterone, OR
  • that has not spread to other parts of the body and no longer responds to a medical or surgical treatment that lowers testosterone.

It is not known if ERLEADA is safe and effective in females.1

It is not known if ERLEADA is safe or effective in children.1

Before taking ERLEADA, tell your healthcare provider about all your medical conditions, including if you1:

  • have a history of heart disease
  • have high blood pressure
  • have diabetes
  • have abnormal amounts of fat or cholesterol in your blood (dyslipidemia)
  • have a history of seizures, brain injury, stroke, or brain tumors
  • are pregnant or plan to become pregnant. ERLEADA can cause harm to your unborn baby and loss of pregnancy (miscarriage).
  • have a partner who is pregnant or may become pregnant.
    • Males who have female partners who are able to become pregnant should use effective birth control (contraception) during treatment and for 3 months after the last dose of ERLEADA.
    • Males should use a condom during sex with a pregnant female.
    • Talk with your healthcare provider if you have questions about birth control.
  • are breastfeeding or plan to breastfeed. It is not known if ERLEADA passes into breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. ERLEADA can interact with many other medicines.1

  • You should not start or stop any medicine before you talk with the healthcare provider that prescribed ERLEADA.1
  • Know the medicines you take. Keep a list of them with you to show to your healthcare provider and pharmacist when you get a new medicine.1

How should I take ERLEADA?

  • Take ERLEADA exactly as your healthcare provider tells you.1
  • Do not stop taking your prescribed dose of ERLEADA without talking with your healthcare provider first.1
  • Take your prescribed dose of ERLEADA 1 time a day, at the same time each day.1
  • Take ERLEADA with or without food.1
  • Swallow ERLEADA tablets whole. Do not crush or split the tablets.1
  • If you cannot swallow ERLEADA tablets whole or if you have a feeding tube, see the “Instructions for Use” of the PRESCRIBING INFORMATION for detailed instructions on how to prepare and take a dose of ERLEADA.1
  • ERLEADA comes in 2 different strengths (60 mg and 240 mg). Follow the instructions for your prescribed strength of ERLEADA.1
  • If you miss a dose of ERLEADA, take your normal dose as soon as possible on the same day. Return to your normal schedule on the following day. You should not take extra tablets to make up the missed dose.1
  • You should start or continue a gonadotropin-releasing hormone (GnRH) analog therapy during your treatment with ERLEADA unless you have had a surgery to lower the amount of testosterone in your body (surgical castration).1
  • If you take too much ERLEADA, call your healthcare provider or go to the nearest hospital emergency room.1

additional information

This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest using it in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.

Please refer to the attached full PRESCRIBING INFORMATION, PATIENT INFORMATION, and the INSTRUCTIONS FOR USE for ERLEADA.1

 

References

1 ERLEADA (apalutamide) [Prescribing Information]. Horsham, PA: Janssen Products, LP;https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/ERLEADA-pi.pdf.